https://priyalifescience.com/article/novo-nordisk-etavopivat-sickle-cell-fda-ema-submission-2026 Priya Life Science en 2026-11-14T15:00:02+00:00 Novo Files Sickle Cell Drug Etavopivat With FDA and EMA https://priyalifescience.com/article/ema-chmp-gazyvaro-obinutuzumab-systemic-lupus-erythematosus-2026 Priya Life Science en 2026-11-14T13:00:02+00:00 EMA Backs Roche's Gazyvaro for Lupus: What Comes Next https://priyalifescience.com/article/eu-approves-novo-nordisk-frehemgo-denecimig-haemophilia-a-2026 Priya Life Science en 2026-11-14T11:00:02+00:00 EU Approves Novo's Frehemgo for Haemophilia A Prophylaxis https://priyalifescience.com/article/osteoporosis-decline-ireland-dexa-study-limerick-2026 Priya Life Science en 2026-11-14T08:30:01+00:00 Osteoporosis Fell Two-Thirds in 26 Years, Irish Study Finds